Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030

icon1
USD 56,945.8 MN
MARKET SIZE, 2030
icon2
CAGR 12.7%
(2024-2030)
icon3
396
REPORT PAGES
icon4
354
MARKET TABLES

OVERVIEW

Remote Patient Monitoring (RPM) Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Remote Patient Monitoring (RPM) market is projected to reach USD 56,945.8 million by 2030 from USD 27,720.5 million in 2024, at a CAGR of 12.7% from 2024 to 2030. The growth of the Remote Patient Monitoring (RPM) market is driven by the transformation of patient care through digital innovation, expansion of telehealth in remote patient monitoring, coupled with the rising prevalence of chronic disease, particularly among the growing geriatric population.

KEY TAKEAWAYS

  • By Region
    The North America Remote Patient Monitoring (RPM) market accounted for a 53.4% revenue share of the global RPM market in 2024.
  • By Component
    By component, the software segment is expected to register the highest CAGR of 14.8%.
  • By Indication
    By Indication, the cardiology segment accounted for the largest share of the global RPM market in 2024.
  • By End User
    By End User, the Patients segment is expected to register the highest CAGR of 13.3%.

The Remote Patient Monitoring (RPM) market is witnessing strong growth driven by digital transformation in patient care, the expansion of telehealth, and the rising burden of chronic diseases. Growing geriatric populations and the need for cost-efficient, home-based care are further boosting adoption. Meanwhile, advances in wearables, mHealth apps, and connected devices are enabling real-time monitoring, predictive insights, and more personalized healthcare delivery.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on consumers’ business in the Remote Patient Monitoring (RPM) market arises from evolving healthcare delivery models and rapid digital disruption. Hospitals, healthcare providers, payers, and homecare organizations are the primary users, leveraging RPM to enhance patient outcomes and operational efficiency. The shift toward continuous, data-driven, and home-based care is transforming clinical workflows, reimbursement structures, and patient engagement models. These changes are redefining how care is delivered and monetized, driving the demand for advanced, interoperable RPM platforms and integrated digital health ecosystems

Remote Patient Monitoring (RPM) Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Transformation of patient care through digital innovation
  • Expansion of telehealth in remote patient monitoring
RESTRAINTS
Impact
Level
  • High investments and lack of IT expertise
  • Behavioral barriers and healthcare affordability challenges in remote patient monitoring
OPPORTUNITIES
Impact
Level
  • Emergence of AI & ML
  • Gradual shift toward outpatient care environments
CHALLENGES
Impact
Level
  • Concerns associated with data security
  • Data accessibility issues

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Transformation of patient care through digital innovation

The transformation of patient care through digital innovation is a key driver of the Remote Patient Monitoring (RPM) market, enabling continuous, data-driven healthcare beyond traditional clinical settings. Advances in connected devices, cloud-based analytics, and AI-powered insights empower clinicians to monitor patients in real time, personalize treatment, and intervene proactively. This digital shift enhances care coordination, improves chronic disease management, reduces hospital readmissions, and promotes patient engagement ultimately driving better outcomes and cost efficiency across the healthcare continuum.

Restraint: High investments and lack of IT expertise

The high initial investments required for implementing Remote Patient Monitoring (RPM) systems, coupled with a shortage of skilled IT professionals, act as major restraints on market growth. Deploying connected devices, cloud infrastructure, and secure data management platforms demands substantial financial and technical resources, which can be challenging for smaller healthcare providers. Additionally, the lack of in-house IT expertise hinders seamless system integration, data interoperability, and ongoing maintenance, limiting the scalability and effectiveness of RPM solutions across healthcare settings.

Opportunity: Emergence of AI & ML

The emergence of Artificial Intelligence (AI) and Machine Learning (ML) presents significant opportunities for the Remote Patient Monitoring (RPM) market. These technologies enable predictive analytics, early detection of health anomalies, and personalized treatment recommendations by analyzing vast amounts of patient data in real time. AI-driven automation can also enhance clinical decision-making, reduce manual workload, and improve patient adherence through intelligent alerts and adaptive monitoring. As AI and ML continue to evolve, they are set to transform RPM solutions into more proactive, precise, and efficient healthcare management tools.

Challenge: Concerns associated with data security

Concerns associated with data security pose a major challenge to the Remote Patient Monitoring (RPM) market. The continuous transmission and storage of sensitive health data across connected devices and cloud platforms increase the risk of cyberattacks, data breaches, and unauthorized access. Ensuring compliance with stringent healthcare data protection regulations, such as HIPAA and GDPR, adds further complexity. These security concerns can undermine patient trust and deter healthcare organizations from fully adopting RPM solutions, emphasizing the need for robust encryption, authentication, and cybersecurity frameworks.

Remote Patient Monitoring (RPM) Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Virtual Care Management and connected monitoring for chronic conditions (diabetes, COPD, heart disease). Reduces hospital readmissions, improves outcomes and patient engagement, lowers care costs.
VitalSight home blood pressure and weight monitoring linked to clinicians. Enables early intervention, better hypertension control, and continuous patient oversight.
MyCareLink Smart and Vital Sync for remote monitoring of implantable and hospital-to-home patients. Early detection of complications, reduced hospital stay and improved chronic care management.
Deployment of RPM/virtual-care solutions by combining GE’s inpatient/acute monitoring portfolio with home-based virtual-care and remote-monitoring Extends hospital-grade monitoring to home, improves capacity, and reduces readmissions.
CardioMEMS HF System for remote monitoring of heart-failure patients. Cuts hospitalizations and mortality, enables proactive treatment, and enhances quality of life.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The remote patient monitoring market's ecosystem comprises entities responsible for the end-to-end workflow of the RPM services workflow. The significant stakeholders present in this market include telecommunications companies, i.e., network, connectivity, and hardware providers; CT tools and electronics manufacturers, i.e., the infrastructure service providers; and service & medical device providers. Healthcare providers (hospitals, health systems, physicians, ACSs, and clinics), Payers, patients/customers, health retailers, senior living/post-acute/hospice centers, start-ups, and governments and regulatory bodies are also stakeholders of this market. Solution and service providers continue to enhance and mature their offerings to increase the value addition. Various hospitals across the world are availing RPM solutions to improve care delivery.

Remote Patient Monitoring (RPM) Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Remote Patient Monitoring (RPM) Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Remote Patient Monitoring (RPM) Market, By Component

As of 2024, the device segment held the largest share of the Remote Patient Monitoring (RPM) market and is expected to maintain its dominance through 2025. This leadership is driven by the widespread adoption of wearable sensors, vital sign monitors, implantable devices, and connected health instruments that enable real-time data collection and continuous patient assessment. These devices are integral to chronic disease management, post-acute care, and preventive health monitoring, offering accuracy, convenience, and early detection of health anomalies. Continuous innovation in miniaturization, connectivity, and integration with AI-powered analytics further strengthens the growth of the device segment within the RPM market.

Remote Patient Monitoring (RPM) Market, By Indication

As of 2024, cardiology accounted for the largest share of the Remote Patient Monitoring (RPM) market and is projected to retain its leading position through 2025. The dominance of this segment is driven by the rising prevalence of cardiovascular diseases, increasing demand for continuous heart health monitoring, and growing use of connected cardiac devices such as ECG monitors, implantable loop recorders, and blood pressure monitors. RPM solutions in cardiology enable early detection of arrhythmias, heart failure, and hypertension, supporting timely intervention and reducing hospital readmissions. The integration of AI and cloud-based analytics further enhances cardiac data interpretation, reinforcing the critical role of RPM in cardiovascular care management.

Remote Patient Monitoring (RPM) Market, By End User

As of 2024, healthcare providers held the largest share of the Remote Patient Monitoring (RPM) market and are expected to continue leading through 2025. This dominance stems from the growing integration of RPM solutions into clinical workflows to enhance patient care, improve treatment adherence, and reduce hospital readmissions. Hospitals, clinics, and home care organizations increasingly rely on connected monitoring systems to manage chronic conditions and track post-discharge patients remotely. The ability of RPM to support value-based care models, optimize resource utilization, and deliver real-time patient insights makes it a critical tool for healthcare providers aiming to improve outcomes and operational efficiency.

REGION

Asia Pacific to be fastest-growing region in global Remote Patient Monitoring (RPM) market during forecast period

The Asia Pacific Remote Patient Monitoring (RPM) market is expected to register the highest CAGR during the forecast period, driven by the rapid digitalization of healthcare systems, growing prevalence of chronic diseases, and increasing government initiatives promoting telehealth and remote care. Countries such as China, India, Japan, and South Korea are witnessing significant adoption of connected health devices and mobile-based monitoring solutions to enhance healthcare accessibility and efficiency. Expanding internet connectivity, rising healthcare expenditure, and strong investments from both public and private sectors are further accelerating the growth of RPM solutions across the region.

Remote Patient Monitoring (RPM) Market Region

Remote Patient Monitoring (RPM) Market: COMPANY EVALUATION MATRIX

In the Remote Patient Monitoring (RPM) market matrix, Abbott (Star) leads with a strong market share and an extensive product portfolio, driven by its advanced connected health devices such as glucose monitors, cardiac rhythm management systems, and wearable biosensors. The company’s focus on continuous innovation, clinical accuracy, and global reach has positioned it as a key enabler of data-driven, patient-centric care. Teladoc Health Inc. (Emerging Leader) is rapidly gaining traction with its expanding virtual care ecosystem that integrates RPM solutions, telehealth services, and AI-powered analytics to enhance chronic disease management and remote patient engagement. While Abbott dominates through technological excellence and scale, Teladoc demonstrates strong potential to advance toward the leaders’ quadrant as it continues to expand its digital health platform and strengthen care continuity across global markets.

Remote Patient Monitoring (RPM) Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 27,720.5 Million
Market Forecast in 2030 (Value) USD 56,945.8 Million
Growth Rate CAGR of 12.7% from 2024-2030
Years Considered 2022-2030
Base Year 2023
Forecast Period 2024-2030
Units Considered Value (USD Million)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Component:
    • Devices
    • Software
    • Services
  • By Indication:
    • Cardiology
    • Diabetes
    • Oncology
    • Neurology
    • Sleep Disorders
    • Wellness Improvement
    • Respiratory Disorders
    • Mental Healt
    • Other Indications
  • By End User:
    • Healthcare Providers
    • Healthcare Payers
    • Patients
    • Pharmaceutical & Biotechnology Companies
    • MedTech Companies
    • Other End Users
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa
Leading Segment Software segment leads with a 14.8% CAGR
Leading Region North America held a 53.4% share of the global RPM market in 2024
Market Driver Digital innovation transforming patient care
Market Constraint High investment needs and limited IT expertise

WHAT IS IN IT FOR YOU: Remote Patient Monitoring (RPM) Market REPORT CONTENT GUIDE

Remote Patient Monitoring (RPM) Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Healthcare Provider
  • Adoption benchmarking of RPM platforms across hospitals and clinics
  • Integration analysis with existing EHR and telehealth systems
  • ROI modeling for chronic care management programs
  • Optimize clinical workflows and patient engagement strategies
  • Identify operational efficiencies and cost savings from remote care
  • Strengthen outcomes-based reimbursement readiness
Device Manufacturer
  • Competitive assessment of RPM device portfolios (wearables, biosensors, implantables)
  • Technology roadmap for connectivity, AI, and interoperability
  • Benchmarking of regulatory approvals and compliance standards
  • Detect product innovation gaps
  • Highlight opportunities for strategic partnerships with health systems
  • Support expansion into new clinical monitoring categories
Payer & Insurance Company
  • Cost-benefit modeling of RPM-enabled care programs
  • Evaluation of reimbursement trends and payer adoption policies
  • Benchmarking of claims data and patient outcome improvement metrics
  • Identify high-value disease management opportunities
  • Strengthen policy frameworks for RPM reimbursement
  • Support population health cost reduction strategies
Software / Platform Developer
  • Evaluation of API integration and interoperability across RPM ecosystems
  • Market mapping of AI-driven analytics platforms
  • Competitive benchmarking of cloud architecture, cybersecurity, and scalability
  • Pinpoint innovation opportunities in predictive analytics
  • Strengthen differentiation through secure, interoperable architectures
  • Accelerate partnerships with device makers and providers
Government / Public Health Agency
  • Assessment of RPM adoption in national telehealth initiatives
  • Policy mapping for remote care reimbursement frameworks
  • Impact analysis on population health management and care accessibility
  • Support digital health policy development
  • Identify infrastructure gaps in rural or underserved regions
  • Strengthen population-level care coordination programs
Home Healthcare Service Provider
  • Operational analysis for scaling home-based RPM programs
  • Mapping of vendor partnerships for device deployment and support
  • Evaluation of patient engagement and adherence analytics
  • Enhance quality-of-care delivery in home settings
  • Strengthen partnerships with payers and hospitals
  • Identify tech-enabled care delivery efficiencies

RECENT DEVELOPMENTS

  • August 2024 : Abbott and Medtronic partnered to integrate its leading FreeStyle Libre continuous glucose monitoring (CGM) technology with Medtronic’s insulin delivery systems, enabling automated insulin adjustments for improved diabetes management. This collaboration expands access to advanced automated insulin delivery solutions for millions of people with diabetes worldwide
  • July 2024 : Bon Secours Mercy Health entered into a 10-year partnership with Philips to implement & scale a new patient monitoring platform across its 49 hospitals and 1,200 care sites.
  • April 2024 : OMRON Healthcare acquired Luscii to enhance its integrated care solutions. This move aimed to accelerate the adoption of remote patient monitoring and support OMRON's "Going for Zero" vision to reduce cardiovascular and cerebrovascular events

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
33
2
RESEARCH METHODOLOGY
 
 
 
40
3
EXECUTIVE SUMMARY
 
 
 
56
4
PREMIUM INSIGHTS
 
 
 
60
5
MARKET OVERVIEW
Digital innovation and AI drive transformative growth in remote patient monitoring and care delivery.
 
 
 
63
 
5.1
INTRODUCTION
 
 
 
 
 
5.1.1
DRIVERS
 
 
 
 
 
5.1.1.1
TRANSFORMATION OF PATIENT CARE THROUGH DIGITAL INNOVATION
 
 
 
 
5.1.1.2
EXPANSION OF TELEHEALTH IN REMOTE PATIENT MONITORING
 
 
 
 
5.1.1.3
RISING PREVALENCE OF CHRONIC DISEASES
 
 
 
 
5.1.1.4
INCREASING GERIATRIC POPULATION AND RISING UPTAKE OF RPM SERVICES
 
 
 
 
5.1.1.5
GROWING NEED FOR COST-CONTAINMENT ACROSS HEALTHCARE FACILITIES
 
 
 
 
5.1.1.6
TECHNOLOGICAL INNOVATION IN WEARABLES, MHEALTH APPS, AND CONNECTED DEVICES
 
 
 
5.1.2
RESTRAINTS
 
 
 
 
 
5.1.2.1
HIGH INVESTMENTS AND LACK OF IT EXPERTISE
 
 
 
 
5.1.2.2
BEHAVIORAL BARRIERS AND HEALTHCARE AFFORDABILITY CHALLENGES IN REMOTE PATIENT MONITORING
 
 
 
 
5.1.2.3
CHALLENGES ASSOCIATED WITH 2024 CMS REGULATIONS
 
 
 
5.1.3
OPPORTUNITIES
 
 
 
 
 
5.1.3.1
EMERGENCE OF AI & ML
 
 
 
 
5.1.3.2
GRADUAL SHIFT TOWARD OUTPATIENT CARE ENVIRONMENTS
 
 
 
 
5.1.3.3
INCREASING UTILIZATION FOR INFECTIOUS DISEASE DIAGNOSTICS
 
 
 
 
5.1.3.4
RISING INITIATIVES FOR HOSPITAL-AT-HOME PROGRAMS
 
 
 
5.1.4
CHALLENGES
 
 
 
 
 
5.1.4.1
CONCERNS ASSOCIATED WITH DATA SECURITY
 
 
 
 
5.1.4.2
DATA ACCESSIBILITY ISSUES
 
 
 
 
5.1.4.3
INCORPORATION OF SDOH FACTORS INTO RPM PROGRAMS
 
 
5.2
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
5.2.1
REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET
 
 
 
5.3
INDUSTRY TRENDS
 
 
 
 
 
5.3.1
GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.6
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.6.1
KEY TECHNOLOGIES
 
 
 
 
 
5.6.1.1
MINIATURE WEARABLE DEVICES
 
 
 
 
5.6.1.2
ARTIFICIAL INTELLIGENCE & MACHINE LEARNING
 
 
 
 
5.6.1.3
CLOUD COMPUTING
 
 
 
 
5.6.1.4
PATIENT ENGAGEMENT TOOLS
 
 
 
 
5.6.1.5
EHR INTEGRATION
 
 
 
 
5.6.1.6
VOICE ASSISTANT INTEGRATION
 
 
 
5.6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.6.2.1
5G CONNECTIVITY
 
 
 
 
5.6.2.2
MHEALTH APPS
 
 
 
 
5.6.2.3
DIGITAL THERAPEUTICS
 
 
 
 
5.6.2.4
TELEHEALTH PLATFORMS
 
 
 
5.6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.6.3.1
POC DIAGNOSTICS
 
 
 
 
5.6.3.2
SMART HOME HEALTH DEVICES
 
 
5.7
TARIFF & REGULATORY ANALYSIS
 
 
 
 
 
5.7.1
TARIFF DATA (HS CODE 9018)
 
 
 
 
5.7.2
TARIFF DATA (HS CODE 9021)
 
 
 
 
5.7.3
TARIFF DATA (HS CODE 9022)
 
 
 
 
5.7.4
REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
 
 
 
 
5.7.5
REGULATORY ANALYSIS
 
 
 
5.8
TRADE ANALYSIS
 
 
 
 
 
 
5.8.1
TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 90189099)
 
 
 
 
5.8.2
TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9021)
 
 
 
 
5.8.3
TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9022)
 
 
 
5.9
PRICING ANALYSIS
 
 
 
 
 
 
5.9.1
INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
 
 
 
 
5.9.2
INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES (2023)
 
 
 
5.10
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.10.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.10.2
THREAT OF SUBSTITUTES
 
 
 
 
5.10.3
BARGAINING POWER OF MANUFACTURERS
 
 
 
 
5.10.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.10.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.11
PATENT ANALYSIS
 
 
 
 
 
 
5.11.1
PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING
 
 
 
 
5.11.2
JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
 
 
 
 
5.11.3
LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET
 
 
 
5.12
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.12.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.12.2
BUYING CRITERIA
 
 
 
5.13
END-USER ANALYSIS
 
 
 
 
 
5.13.1
UNMET NEEDS
 
 
 
 
5.13.2
END-USER EXPECTATIONS
 
 
 
5.14
KEY CONFERENCES AND EVENTS, 2025−2026
 
 
 
 
 
5.14.1
REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025−2026
 
 
 
5.15
CASE STUDY ANALYSIS
 
 
 
 
 
5.15.1
REMOTE PATIENT MONITORING PORTAL AUTOMATION
 
 
 
 
 
5.15.1.1
CASE 1: COST SAVINGS AND PERFORMANCE BOOST THROUGH AUTOMATION
 
 
 
5.15.2
PATIENT MONITORING PORTAL AUTOMATION
 
 
 
 
 
5.15.2.1
CASE 2: RPM DRIVES ENGAGEMENT AND GENERATES SUBSTANTIAL RETURNS
 
 
5.16
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.17
REMOTE PATIENT MONITORING BUSINESS MODEL
 
 
 
 
 
5.17.1
SUBSCRIPTION-BASED MODELS
 
 
 
 
5.17.2
PLATFORM AS A SERVICE (PAAS)
 
 
 
 
5.17.3
FREEMIUM MODELS WITH PREMIUM FEATURES
 
 
 
 
5.17.4
COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS
 
 
 
5.18
IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET
 
 
 
 
 
5.18.1
KEY USE CASES
 
 
 
 
5.18.2
CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION
 
 
 
 
 
5.18.2.1
CASE STUDY 1: ENHANCING REMOTE PATIENT MONITORING FOR CANCER TREATMENT WITH NLP AND HIPAA-COMPLIANT ANNOTATION
 
 
 
 
5.18.2.2
CASE STUDY 2: LEVERAGING AI FOR PROACTIVE INFECTION PREVENTION IN HOSPITALS
 
 
 
5.18.3
IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
 
 
 
 
 
5.18.3.1
TELEHEALTH & TELEMEDICINE
 
 
 
 
5.18.3.2
WEARABLE DEVICES
 
 
 
 
5.18.3.3
DIGITAL HEALTHCARE
 
 
 
 
5.18.3.4
HOME HEALTHCARE
 
 
 
5.18.4
USER READINESS & IMPACT ASSESSMENT
 
 
 
 
 
5.18.4.1
USER READINESS
 
 
 
 
5.18.4.2
IMPACT ASSESSMENT
 
 
5.19
REIMBURSEMENT SCENARIO
 
 
 
6
REMOTE PATIENT MONITORING MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 27 Data Tables
 
 
 
126
 
6.1
INTRODUCTION
 
 
 
 
6.2
DEVICES
 
 
 
 
 
6.2.1
BY FUNCTION
 
 
 
 
 
6.2.1.1
CARDIAC MONITORING DEVICES
 
 
 
 
6.2.1.2
NEUROLOGICAL MONITORING DEVICES
 
 
 
 
6.2.1.3
RESPIRATORY MONITORING DEVICES
 
 
 
 
6.2.1.4
BLOOD GLUCOSE MONITORING DEVICES
 
 
 
 
6.2.1.5
FETAL & NEONATAL MONITORING DEVICES
 
 
 
 
6.2.1.6
WEIGHT MONITORING DEVICES
 
 
 
 
6.2.1.7
MULTIPARAMETER MONITORING DEVICES
 
 
 
 
6.2.1.8
PULSE OXIMETER DEVICES
 
 
 
 
6.2.1.9
THERMOMETERS
 
 
 
 
6.2.1.10
OTHER MONITORING DEVICES
 
 
 
6.2.2
BY TYPE
 
 
 
 
 
6.2.2.1
WEARABLE DEVICES
 
 
 
 
6.2.2.2
IMPLANTABLE DEVICES
 
 
 
 
6.2.2.3
HANDHELD & PORTABLE DEVICES
 
 
 
 
6.2.2.4
OTHER DEVICES
 
 
6.3
SOFTWARE
 
 
 
 
 
6.3.1
SOFTWARE, BY DEPLOYMENT MODEL
 
 
 
 
 
6.3.1.1
ON-PREMISE MODELS
 
 
 
 
6.3.1.2
CLOUD-BASED MODELS
 
 
 
6.3.2
SOFTWARE, BY TRANSMISSION TYPE
 
 
 
 
 
6.3.2.1
SYNCHRONOUS TRANSMISSION
 
 
 
 
6.3.2.2
ASYNCHRONOUS TRANSMISSION
 
 
6.4
SERVICES
 
 
 
 
 
6.4.1
EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH
 
 
7
REMOTE PATIENT MONITORING MARKET, BY INDICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
150
 
7.1
INTRODUCTION
 
 
 
 
7.2
ONCOLOGY
 
 
 
 
 
7.2.1
GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
 
 
 
7.3
CARDIOLOGY
 
 
 
 
 
7.3.1
HIGH INCIDENCE OF CVD TO PROPEL MARKET
 
 
 
7.4
NEUROLOGY
 
 
 
 
 
7.4.1
INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS TO FUEL MARKET
 
 
 
7.5
DIABETES
 
 
 
 
 
7.5.1
GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND
 
 
 
7.6
SLEEP DISORDERS
 
 
 
 
 
7.6.1
INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH
 
 
 
7.7
RESPIRATORY DISEASES
 
 
 
 
 
7.7.1
RISING CASES OF COPD AND ASTHMA TO FUEL MARKET
 
 
 
7.8
WELLNESS IMPROVEMENT
 
 
 
 
 
7.8.1
UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH APPS TO SUPPORT MARKET GROWTH
 
 
 
7.9
MENTAL HEALTH
 
 
 
 
 
7.9.1
GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS FOR COGNITIVE THERAPY TO PROPEL MARKET
 
 
 
7.10
OTHER INDICATIONS
 
 
 
8
REMOTE PATIENT MONITORING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 13 Data Tables
 
 
 
162
 
8.1
INTRODUCTION
 
 
 
 
8.2
HEALTHCARE PROVIDERS
 
 
 
 
 
8.2.1
HOSPITALS
 
 
 
 
 
8.2.1.1
ABILITY TO PURCHASE TECHNOLOGICALLY ADVANCED TELEHEALTH DEVICES TO FUEL MARKET
 
 
 
8.2.2
ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
 
 
 
 
 
8.2.2.1
INCREASING DEMAND FOR COST-EFFECTIVE PERIOPERATIVE DEVICES TO FUEL MARKET
 
 
 
8.2.3
LONG-TERM CARE & ASSISTED LIVING FACILITIES
 
 
 
 
 
8.2.3.1
EXPANDING GERIATRIC POPULATION AND GROWING FOCUS ON CHRONIC DISEASE MANAGEMENT TO FUEL MARKET
 
 
 
8.2.4
HOME HEALTHCARE
 
 
 
 
 
8.2.4.1
GROWING PREFERENCE FOR REMOTE CARE TO DRIVE MARKET
 
 
 
8.2.5
OTHER HEALTHCARE PROVIDERS
 
 
 
8.3
HEALTHCARE PAYERS
 
 
 
 
 
8.3.1
LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET
 
 
 
8.4
PATIENTS
 
 
 
 
 
8.4.1
INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES TO BOOST DEMAND
 
 
 
8.5
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
8.5.1
RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES TO SUPPORT MARKET GROWTH
 
 
 
8.6
MEDTECH COMPANIES
 
 
 
 
 
8.6.1
INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR DIAGNOSTIC ACCURACY TO FUEL MARKET
 
 
 
8.7
OTHER END USERS
 
 
 
9
REMOTE PATIENT MONITORING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 181 Data Tables.
 
 
 
174
 
9.1
INTRODUCTION
 
 
 
 
9.2
NORTH AMERICA
 
 
 
 
 
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
9.2.2
US
 
 
 
 
 
9.2.2.1
SUPPORTIVE REGULATORY FRAMEWORKS FOR AI IMPLEMENTATION IN WEARABLE DEVICES TO BOOST DEMAND
 
 
 
9.2.3
CANADA
 
 
 
 
 
9.2.3.1
GROWING NEED TO CURTAIL HEALTHCARE COSTS TO DRIVE MARKET
 
 
9.3
EUROPE
 
 
 
 
 
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
9.3.2
GERMANY
 
 
 
 
 
9.3.2.1
FAVORABLE REIMBURSEMENTS FOR TECHNOLOGICAL INNOVATION TO PROPEL MARKET
 
 
 
9.3.3
UK
 
 
 
 
 
9.3.3.1
GOVERNMENT SUPPORT FOR AI IMPLEMENTATION TO BOOST DEMAND
 
 
 
9.3.4
FRANCE
 
 
 
 
 
9.3.4.1
IMPLEMENTATION OF ETAPES PROGRAM TO FUEL MARKET
 
 
 
9.3.5
ITALY
 
 
 
 
 
9.3.5.1
GROWING FOCUS ON DIGITAL TRANSFORMATION FOR VALUE-CENTRIC PATIENT CARE TO DRIVE MARKET
 
 
 
9.3.6
SPAIN
 
 
 
 
 
9.3.6.1
RISING FUNDING INVESTMENTS FOR DIGITAL HEALTH PLANS TO BOOST MARKET
 
 
 
9.3.7
REST OF EUROPE
 
 
 
9.4
ASIA PACIFIC
 
 
 
 
 
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
9.4.2
CHINA
 
 
 
 
 
9.4.2.1
SHORTAGE OF PHYSICIANS AND GROWING FOCUS ON RPM SOLUTIONS TO SUPPORT MARKET GROWTH
 
 
 
9.4.3
JAPAN
 
 
 
 
 
9.4.3.1
RISING GERIATRIC POPULATION AND SUBSEQUENT RISE IN PREVENTIVE CARE TO DRIVE MARKET
 
 
 
9.4.4
INDIA
 
 
 
 
 
9.4.4.1
EXPANDING TARGET PATIENT POPULATION TO DRIVE MARKET
 
 
 
9.4.5
REST OF ASIA PACIFIC
 
 
 
9.5
LATIN AMERICA
 
 
 
 
 
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
9.5.2
BRAZIL
 
 
 
 
 
9.5.2.1
GROWING FOCUS ON TELEHEALTH CONSULTATIONS TO DRIVE MARKET
 
 
 
9.5.3
MEXICO
 
 
 
 
 
9.5.3.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO BOOST DEMAND
 
 
 
9.5.4
REST OF LATIN AMERICA
 
 
 
9.6
MIDDLE EAST & AFRICA
 
 
 
 
9.7
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
 
9.7.1
GCC COUNTRIES
 
 
 
 
 
9.7.1.1
GOVERNMENT INITIATIVES FOR INVESTMENTS IN RPM SOLUTIONS TO SUPPORT MARKET GROWTH
 
 
 
9.7.2
REST OF MIDDLE EAST & AFRICA
 
 
10
COMPETITIVE LANDSCAPE
Uncover key strategies driving market dominance in remote patient monitoring's competitive landscape.
 
 
 
269
 
10.1
OVERVIEW
 
 
 
 
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET
 
 
 
10.3
REVENUE ANALYSIS, 2019–2023
 
 
 
 
 
10.4
MARKET SHARE ANALYSIS, 2023
 
 
 
 
 
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
 
 
 
 
 
 
10.5.1
STARS
 
 
 
 
10.5.2
EMERGING LEADERS
 
 
 
 
10.5.3
PERVASIVE PLAYERS
 
 
 
 
10.5.4
PARTICIPANTS
 
 
 
 
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
 
 
 
 
 
10.5.5.1
COMPANY FOOTPRINT
 
 
 
 
10.5.5.2
REGION FOOTPRINT
 
 
 
 
10.5.5.3
COMPONENT FOOTPRINT
 
 
 
 
10.5.5.4
INDICATION FOOTPRINT
 
 
 
 
10.5.5.5
END-USER FOOTPRINT
 
 
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
10.6.1
PROGRESSIVE COMPANIES
 
 
 
 
10.6.2
RESPONSIVE COMPANIES
 
 
 
 
10.6.3
DYNAMIC COMPANIES
 
 
 
 
10.6.4
STARTING BLOCKS
 
 
 
 
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
 
 
 
 
 
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
10.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
10.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
10.7.1
FINANCIAL METRICS
 
 
 
 
10.7.2
COMPANY VALUATION
 
 
 
10.8
BRAND/SOFTWARE COMPARISON
 
 
 
 
10.9
COMPETITIVE SCENARIO
 
 
 
 
 
10.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
 
 
 
 
10.9.2
DEALS
 
 
 
 
10.9.3
EXPANSIONS
 
 
 
 
10.9.4
OTHER DEVELOPMENTS
 
 
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
297
 
11.1
KEY PLAYERS
 
 
 
 
 
11.1.1
KONINKLIJKE PHILIPS N.V.
 
 
 
 
 
11.1.1.1
BUSINESS OVERVIEW
 
 
 
 
11.1.1.2
PRODUCTS/SERVICES OFFERED
 
 
 
 
11.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
11.1.1.4
MNM VIEW
 
 
 
11.1.2
OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION)
 
 
 
 
11.1.3
MEDTRONIC
 
 
 
 
11.1.4
GE HEALTHCARE
 
 
 
 
11.1.5
ABBOTT
 
 
 
 
11.1.6
ORACLE
 
 
 
 
11.1.7
BOSTON SCIENTIFIC CORPORATION
 
 
 
 
11.1.8
NIHON KOHDEN CORPORATION
 
 
 
 
11.1.9
SIEMENS HEALTHINEERS AG
 
 
 
 
11.1.10
BAXTER
 
 
 
 
11.1.11
BIOBEAT
 
 
 
 
11.1.12
BIOTRONIK
 
 
 
 
11.1.13
VITALCONNECT
 
 
 
 
11.1.14
VIVALNK, INC.
 
 
 
 
11.1.15
CLEARARCH, INC.
 
 
 
 
11.1.16
OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM)
 
 
 
 
11.1.17
BLUE SPARK TECHNOLOGIES, INC.
 
 
 
 
11.1.18
LIGHTBEAM
 
 
 
 
11.1.19
CLOUD DIAGNOSTICS CANADA ULC
 
 
 
 
11.1.20
TELADOC HEALTH, INC.
 
 
 
 
11.1.21
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.
 
 
 
11.2
OTHER PLAYERS
 
 
 
 
 
11.2.1
CARESIMPLE INC.
 
 
 
 
11.2.2
TIMEDOC, INC.
 
 
 
 
11.2.3
MD REVOLUTION INC.
 
 
 
 
11.2.4
OPTIMIZE HEALTH, INC.
 
 
 
 
11.2.5
HEALTH RECOVERY SOLUTIONS
 
 
12
APPENDIX
 
 
 
386
 
12.1
DISCUSSION GUIDE
 
 
 
 
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
12.3
CUSTOMIZATION OPTIONS
 
 
 
 
12.4
RELATED REPORTS
 
 
 
 
12.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
 
 
 
 
TABLE 2
FACTOR ANALYSIS
 
 
 
 
TABLE 3
RISK ASSESSMENT: REMOTE PATIENT MONITORING MARKET
 
 
 
 
TABLE 4
REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS
 
 
 
 
TABLE 5
RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022–DECEMBER 2024
 
 
 
 
TABLE 6
TOP 5 HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES
 
 
 
 
TABLE 7
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 8
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 9
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
NORTH AMERICA: REGULATORY ANALYSIS
 
 
 
 
TABLE 13
EUROPE: REGULATORY ANALYSIS
 
 
 
 
TABLE 14
ASIA PACIFIC: REGULATORY ANALYSIS
 
 
 
 
TABLE 15
MIDDLE EAST & AFRICA: REGULATORY ANALYSIS
 
 
 
 
TABLE 16
LATIN AMERICA: REGULATORY ANALYSIS
 
 
 
 
TABLE 17
INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
 
 
 
 
TABLE 18
AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICE (2023)
 
 
 
 
TABLE 19
INDICATIVE PRICE OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023 (USD)
 
 
 
 
TABLE 20
REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 21
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
 
 
 
 
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USERS
 
 
 
 
TABLE 23
KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING
 
 
 
 
TABLE 24
UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET
 
 
 
 
TABLE 25
END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET
 
 
 
 
TABLE 26
CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET
 
 
 
 
TABLE 27
REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 28
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 29
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 30
CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 31
NEUROLOGICAL MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 32
RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 33
BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 34
FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 35
WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 36
MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 37
PULSE OXIMETER DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 38
THERMOMETERS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 39
OTHER MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 40
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 41
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 42
WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 43
IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 44
HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 45
OTHER DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 46
REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 47
REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 48
ON-PREMISE MODELS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 49
CLOUD-BASED MODELS MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 50
REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 51
SYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 52
ASYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 53
REMOTE PATIENT MONITORING MARKET FOR SERVICES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 54
REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 55
REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 56
REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 57
REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 58
REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 59
REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 60
REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 61
REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 62
REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 63
REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 64
REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 65
REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 66
REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 67
REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 68
REMOTE PATIENT MONITORING MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 69
REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 70
REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 71
REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 72
REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 73
REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 74
REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 75
REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 76
REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 77
REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 78
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 79
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 80
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 81
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 82
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 83
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 84
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 85
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 86
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 87
US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 88
US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 89
US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 90
US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 91
US: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 92
US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 93
US: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 94
CANADA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 95
CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 96
CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 97
CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 98
CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 99
CANADA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 100
CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 101
CANADA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 102
EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 103
EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 104
EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 105
EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 106
EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 107
EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 108
EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 109
EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 110
EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 111
GERMANY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 112
GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 113
GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 114
GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 115
GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 116
GERMANY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 117
GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 118
GERMANY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 119
UK: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 120
UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 121
UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 122
UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 123
UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 124
UK: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 125
UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 126
UK: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 127
FRANCE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 128
FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 129
FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 130
FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 131
FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 132
FRANCE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 133
FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 134
FRANCE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 135
ITALY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 136
ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 137
ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 138
ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 139
ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 140
ITALY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 141
ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 142
ITALY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 143
SPAIN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 144
SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 145
SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 146
SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 147
SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 148
SPAIN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 149
SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 150
SPAIN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 151
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 152
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 153
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 154
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 155
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 156
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 157
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 158
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 159
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 160
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 161
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 162
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 163
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 164
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 165
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 166
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 167
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 168
CHINA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 169
CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 170
CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 171
CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 172
CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 173
CHINA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 174
CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 175
CHINA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 176
JAPAN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 177
JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 178
JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 179
JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 180
JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 181
JAPAN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 182
JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 183
JAPAN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 184
INDIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 185
INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 186
INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 187
INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 188
INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 189
INDIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 190
INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 191
INDIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 192
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 193
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 194
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 195
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 196
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 197
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 198
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 199
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 200
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 201
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 202
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 203
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 204
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 205
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 206
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 207
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 208
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 209
BRAZIL: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 210
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 211
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 212
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 213
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 214
BRAZIL: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 215
BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 216
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 217
MEXICO: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 218
MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 219
MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 220
MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 221
MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 222
MEXICO: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 223
MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 224
MEXICO: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 225
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 226
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 227
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 228
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 229
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 230
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 231
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 232
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 233
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 234
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 235
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 236
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 237
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 238
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 239
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 240
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 241
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 242
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 243
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 244
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 245
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 246
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 247
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 248
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 249
GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 250
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 251
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 252
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 253
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 254
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 255
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 256
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 257
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
 
 
 
 
TABLE 258
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 259
REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 260
REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 261
REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
 
 
 
 
TABLE 262
REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
 
 
 
 
TABLE 263
REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 264
REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
TABLE 265
REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
 
 
 
 
TABLE 266
REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 267
REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 268
REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 269
REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 270
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
 
 
 
 
TABLE 271
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 272
KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 273
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 274
OMRON CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 275
OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 276
OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 277
OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 278
OMRON HEALTHCARE, INC.: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 279
MEDTRONIC: COMPANY OVERVIEW
 
 
 
 
TABLE 280
MEDTRONIC: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 281
MEDTRONIC: PRODUCT/SERVICE APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 282
MEDTRONIC: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 283
GE HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
TABLE 284
GE HEALTHCARE: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 285
GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 286
GE HEALTHCARE: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 287
ABBOTT: COMPANY OVERVIEW
 
 
 
 
TABLE 288
ABBOTT: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 289
ABBOTT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 290
ABBOTT: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 291
ABBOTT: EXPANSIONS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 292
ORACLE: COMPANY OVERVIEW
 
 
 
 
TABLE 293
ORACLE: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 294
ORACLE: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 295
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 296
BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 297
BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 298
BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 299
BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 300
NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 301
NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 302
NIHON KOHDEN CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 303
NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 304
NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 305
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
 
 
 
 
TABLE 306
SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 307
SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 308
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 309
BAXTER: COMPANY OVERVIEW
 
 
 
 
TABLE 310
BAXTER: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 311
BAXTER: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 312
BAXTER: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 313
BIOBEAT: COMPANY OVERVIEW
 
 
 
 
TABLE 314
BIOBEAT: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 315
BIOBEAT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 316
BIOBEAT: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 317
BIOTRONIK: COMPANY OVERVIEW
 
 
 
 
TABLE 318
BIOTRONIK: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 319
BIOTRONIK: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 320
BIOTRONIK: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 321
VITALCONNECT: COMPANY OVERVIEW
 
 
 
 
TABLE 322
VITALCONNECT: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 323
VITALCONNECT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 324
VITALCONNECT: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 325
VITALCONNECT: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 326
VIVALNK, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 327
VIVALNK, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 328
VIVALNK, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 329
VIVALNK, INC.: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 330
CLEARARCH, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 331
CLEARARCH, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 332
CLEARARCH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 333
CLEARARCH, INC.: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 334
OPTUM, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 335
OPTUM, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 336
BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 337
BLUE SPARK TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 338
BLUE SPARK TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 339
BLUE SPARK TECHNOLOGIES, INC.: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 340
BLUE SPARK TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 341
LIGHTBEAM: COMPANY OVERVIEW
 
 
 
 
TABLE 342
LIGHTBEAM: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 343
LIGHTBEAM: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 344
CLOUD DIAGNOSTICS CANADA ULC: COMPANY OVERVIEW
 
 
 
 
TABLE 345
CLOUD DIAGNOSTICS CANADA ULC: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 346
CLOUD DIAGNOSTICS CANADA ULC: PRODUCT LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 347
CLOUD DIAGNOSTICS CANADA ULC: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 348
TELADOC HEALTH, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 349
TELADOC HEALTH, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 350
TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 351
TELADOC HEALTH, INC.: DEALS, JANUARY 2021−JANUARY 2025
 
 
 
 
TABLE 352
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 353
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 354
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
REMOTE PATIENT MONITORING MARKET SEGMENTATION
 
 
 
 
FIGURE 2
RESEARCH DESIGN
 
 
 
 
FIGURE 3
PRIMARY SOURCES
 
 
 
 
FIGURE 4
INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 6
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
FIGURE 7
SUPPLY-SIDE MARKET ESTIMATION
 
 
 
 
FIGURE 8
REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH
 
 
 
 
FIGURE 9
BOTTOM-UP APPROACH: END-USER SPENDING ON REMOTE PATIENT MONITORING
 
 
 
 
FIGURE 10
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
 
 
 
 
FIGURE 11
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 12
TOP-DOWN APPROACH
 
 
 
 
FIGURE 13
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 14
REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT
 
 
 
 
FIGURE 18
TRANSFORMATION OF PATIENT CARE THROUGH DIGITIZATION TO PROPEL MARKET
 
 
 
 
FIGURE 19
HEALTHCARE PROVIDERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
 
 
 
 
FIGURE 20
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
FIGURE 21
EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 22
REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 23
DIGITAL HEALTH FUNDING HISTORY, 2020−2024 (USD BILLION)
 
 
 
 
FIGURE 24
NUMBER OF DEALS IN DIGITAL HEALTH (2020−2024)
 
 
 
 
FIGURE 25
US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024)
 
 
 
 
FIGURE 26
HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009–2024
 
 
 
 
FIGURE 27
HEALTHCARE SECURITY BREACHES, 2009–2023
 
 
 
 
FIGURE 28
REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 29
REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 30
IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 31
EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 32
IMPORT OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 33
EXPORTS OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 34
IMPORT OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 35
EXPORTS OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 36
REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 37
GLOBAL PATENT PUBLICATION TRENDS IN REMOTE PATIENT MONITORING MARKET, 2015–2024
 
 
 
 
FIGURE 38
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS (JANUARY 2015–NOVEMBER 2024)
 
 
 
 
FIGURE 39
LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–NOVEMBER 2024)
 
 
 
 
FIGURE 40
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING
 
 
 
 
FIGURE 41
KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY COMPONENT
 
 
 
 
FIGURE 42
POTENTIAL OF GENERATIVE AI/AI IN REMOTE PATIENT MONITORING ACROSS INDUSTRIES
 
 
 
 
FIGURE 43
NEW CANCER CASES IN US, 2024
 
 
 
 
FIGURE 44
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT
 
 
 
 
FIGURE 45
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT
 
 
 
 
FIGURE 46
REVENUE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)
 
 
 
 
FIGURE 47
MARKET SHARE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET (2023)
 
 
 
 
FIGURE 48
REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
 
 
 
 
FIGURE 49
REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 50
REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
 
 
 
 
FIGURE 51
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 52
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 53
REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 54
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 55
OMRON CORPORATION: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 56
MEDTRONIC: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 57
GE HEALTHCARE: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 58
ABBOTT: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 59
ORACLE: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 60
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 61
NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 62
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 63
BAXTER: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 64
TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2023)
 
 
 
 

Methodology

The study involved major activities in estimating the current market size for the remote patient monitoring market. Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

The following is a breakdown of the primary respondents:

Remote Patient Monitoring (RPM) Market

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following:

Remote Patient Monitoring (RPM) Market

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

Market Definition

The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

Stakeholders

  • RPM Equipment and devices Manufacturers
  • Suppliers and Distributors of RPM Equipment
  • RPM software provider
  • Healthcare IT Service Providers
  • Healthcare Insurance Companies/Payers
  • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
  • Venture Capitalists
  • Government Bodies/Regulatory Bodies
  • Corporate Entities
  • Accountable Care Organizations
  • RPM Resource Centers
  • Research and Consulting Firms
  • Medical Research Institutes
  • Clinical Departments

Report Objectives

  • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, funding, grant, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

 

Key Questions Addressed by the Report

Which are the top industry players in the global Remote patient monitoring?
The top market players in the global Remote patient monitoring include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), VitalConnect (US), VivaLNK, Inc (US), Clear Arch, Inc (US), Optum, Inc (Vivifyhealth) (US), Blue Spark Technologies, Inc (US), Lightbeam (US), Cloud Diagnostics Canada ULC (Canada), Teladoc Health, Inc (US), and Guangdong Transtek Medical Electronics Co., Ltd (China).
Which component type has been included in the Remote patient monitoring report?
This report contains the following components:
  • Devices
    • By Function
      • Cardiac monitoring devices
      • Neurological monitoring devices
      • Respiratory monitoring devices
      • Blood glucose monitoring devices
      • Fetal & neonatal monitoring devices
      • Weight monitoring devices
      • Multiparameter monitoring devices
      • Pulse oximeter devices
      • Thermometers
      • Other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)
    • By Product type
      • Wearable devices
      • Implantable devices
      • Handheld & portable devices
      • Others (stationary devices, and others)
  • Software
    • By deployment model
      • On-premise model
      • Cloud-based model
    • By transmission type
      • Synchronous
      • Asynchronous
  • Services
Which region dominates the global Remote patient monitoring?
The global Remote patient monitoring is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds a substantial share, and the Asia Pacific is expected to register the highest growth rate during the forecast period.
Which end users have been included in the Remote patient monitoring report?
The report contains the following industry segments:
  • Healthcare Providers
    • Hospitals
    • Ambulatory surgical centers, ambulatory care centers, and other outpatient settings
    • Long-term care & assisted living facilities 
    • Home healthcare
    • Other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)
  • Healthcare payers
  • Patients
  • Pharmaceutical & biotechnology companies
  • MedTech companies
  • Other end users (employer groups, government organizations, academic institutes, research centers, and others)
What is the total CAGR expected to be recorded for the Remote patient monitoring during 2024-2030?
The market is expected to record a CAGR of 12.7% from 2024–2030.

 

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Remote Patient Monitoring (RPM) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Remote Patient Monitoring (RPM) Market

Chad

Nov, 2021

Can you explain your reasoning around the projection of the $72.8 Billion Mkt for RPM in North America? Thanks.

Amber

Mar, 2022

Which are growth driving factors for the global growth of Remote Patient Monitoring Market?.

Willie

Mar, 2022

What will be the size of the Remote Patient Monitoring Market for the European region?.

DMCA.com Protection Status